NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production

• Published in: The Journal of neuroscience Vol. 25; no. 41; pp. 9367 - 9377
• Main Authors: Lesné, Sylvain, Ali, Carine, Gabriel, Cecília, Croci, Nicole, MacKenzie, Eric T, Glabe, Charles G, Plotkine, Michel, Marchand-Verrecchia, Catherine, Vivien, Denis, Buisson, Alain
• Format: Journal Article
• Language: English
• Published: United States Society for Neuroscience 12-10-2005
• Subjects: Amyloid beta-Peptides - biosynthesis; Amyloid beta-Peptides - genetics; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cells, Cultured; Endopeptidases - genetics; Endopeptidases - metabolism; Excitatory Amino Acid Agonists - pharmacology; Humans; Mice; N-Methylaspartate - pharmacology; Neurobiology of Disease; Neurons - drug effects; Neurons - metabolism; Protease Inhibitors - pharmacology; Receptors, N-Methyl-D-Aspartate - agonists; Receptors, N-Methyl-D-Aspartate - metabolism; Receptors, N-Methyl-D-Aspartate - physiology
• ISSN: 0270-6474; 1529-2401
• DOI: 10.1523/JNEUROSCI.0849-05.2005

Acute brain injuries have been identified as a risk factor for developing Alzheimer's disease (AD). Because glutamate plays a pivotal role in these pathologies, we studied the influence of glutamate receptor activation on amyloid-beta (Abeta) production in primary cultures of cortical neurons. We found that sublethal NMDA receptor activation increased the production and secretion of Abeta. This effect was preceded by an increased expression of neuronal Kunitz protease inhibitory domain (KPI) containing amyloid-beta precursor protein (KPI-APP) followed by a shift from alpha-secretase to beta-secretase-mediated APP processing. This shift is a result of the inhibition of the alpha-secretase candidate tumor necrosis factor-alpha converting enzyme (TACE) when associated with neuronal KPI-APPs. This KPI-APP/TACE interaction was also present in AD brains. Thus, our findings reveal a cellular mechanism linking NMDA receptor activation to neuronal Abeta secretion. These results suggest that even mild deregulation of the glutamatergic neurotransmission may increase Abeta production and represent a causal risk factor for developing AD.